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Bone marrow–induced behavior?
Hoxb8 mutant mice exhibit excessive pathological groom-
ing behaviors that are similar in nature to the human obses-
sive–compulsive disorder trichotillomania. Hox genes are 
typically involved in establishing body plans, although 
these genes also play a direct role in formation of the 
hematopoietic system. The brain is responsible for imple-
menting grooming behavior, and Chen and colleagues 
recently demonstrated that the only detectable cells derived 
from the Hoxb8 cell lineage in the brain were microglia. 
Surprisingly, transplantation of wild-type bone marrow 
into irradiated Hoxb8 mutant mice rescued the pathologi-
cal grooming behavior, despite the spinal cord defects that 
are present in these mutant mice. In agreement with this 
finding, restricted deletion of Hoxb8 in hematopoietic cells 
induced the excessive grooming phenotype. Taken together, 
these results suggest that the pathological grooming behav-
ior observed in Hoxb8 mice results from a deficiency in 
bone marrow-derived microglia. (Cell 141:775–85, 2010)
Improving DC homing
Development of dendritic cell (DC)-based tumor immu-
notherapy has been the focus of intensive research efforts. 
Unfortunately, poor mobilization of adoptively transferred 
antigen-pulsed DCs to draining lymph nodes (DLNs) has 
limited the efficacy of such treatments. Previous studies 
have indicated that mast cell activation and mast cell–
derived tumor necrosis factor (TNF)-α are important for 
efficient Langerhans cell migration to DLNs. Ren and col-
leagues found that homing of bone marrow-derived (BM)-
DCs to DLNs increased following mast cell activation and 
degranulation. Intradermal injection of the known mast 
cell activator c48/80 induced BM-DC migration to the 
DLNs. In addition, this induced mast cell degranulation 
also enhanced antigen-pulsed BM-DC-mediated immune 
responses, such as antigen-specific lymphocyte prolif-
eration and cytokine production. These results provide a 
potential mechanism for improvement of DC-based immu-
notherapies. (Cell Immunol 263:204–11, 2010)
Beneath the epidermis
Inhibition of tumor blood flow and neoangiogenesis has 
been the target for new approaches to cancer therapy. Protein 
kinase C (PKC) regulates keratinocyte viability and is often 
inactivated or downregulated in squamous cell tumors, sug-
gesting that this kinase is a suitable target for tumor therapy. 
Indeed, ingenol-3-angelate (Ing3A) exhibits antitumor activi-
ty upon topical application, and this drug, which is in clinical 
trials for treatment of basal cell carcinoma, actinic keratosis, 
and squamous cell carcinoma, is a PKC agonist. Recently, Li 
and colleagues showed that this drug engages the epidermis, 
but, unlike the similar protumor factor phorbol 12-myristate 
13-acetate, Ing3A penetrated through the epidermis to the 
dermis and subcutis where the vasculature resides. In these 
experiments, Ing3A bound to P-glycoprotein (P-gp), a factor 
that is linked to the development of multidrug resistance in 
cancer cells, and P-gp transported this drug through the ABC 
transporter ABCB1 to subepidermal compartments. Given 
that the skin is increasingly considered an advantageous site 
for drug delivery, future studies of the absorption and effects 
of this drug as well as of the impacts of polymorphisms in 
the human ABCB1 gene (MDR1) are warranted. (Cancer Res 
70:4509–19, 2010)
Autonomous contribution of mTECs
Medullary thymic epithelial cells (mTECs) function in the 
generation of a self-tolerant T-cell repertoire. Although these 
cells express peripheral-tissue antigens, the function of 
mTECs as antigen-presenting cells is not clearly understood. 
After decreasing the major histocompatibility complex class 
II molecules on mTECs in order to maintain the functional 
properties of these cells, Hinterberger and colleagues found 
an enlarged CD4 single-positive T-cell compartment in these 
mice. These findings indicate that mTECs contribute to dele-
tional CD4+ tolerance by acting as antigen-presenting cells. 
Furthermore, antigen recognition on mTECs enhanced the 
development of regulatory T cells. Together, these results 
demonstrate that mTECs autonomously contribute to central 
CD4+ T-cell tolerance. (Nat Immunol 11:512–9, 2010)
Engineering strategies for gene therapy
A tumor-reactive T-cell repertoire can be generated via 
introduction of genes that encode tumor-reactive T-cell 
receptor (TCR) αβ chains into peripheral T cells; however, 
these TCR chains may form TCRs that yield self-reactive T 
cells. Bendle and colleagues recently introduced such an 
antigen-specific TCR into murine T cells and found that a 
lethal autoimmune pathology resulted because of the for-
mation of self-antigen-reactive mixed TCR dimers. This so-
called transfer-induced graft-versus-host disease could be 
limited or prevented using strategies that result in reduced 
pairing of endogenous and exogenous TCR chains or in a 
limited diversity of endogenous TCR repertoire of the trans-
duced T cells. These strategies, which included the addition 
of a disulfide bond between the α and β chains as well as 
replacement of the sequence that links these chains with 
the porcine teschovirus–derived P2A sequence, may be 
useful in preventing an otherwise fatal autoimmune attack 
following tumor-specific gene therapy; these engineering 
strategies will be examined further in the clinical setting. 
(Nat Med 16:565–70, 2010)
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